CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
130 hedge funds and large institutions have $251M invested in Cymabay Therapeutics in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
130
Holders Change
-15
Holders Change %
-10.34%
% of All Funds
2.29%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
18
Increased
46
Reduced
34
Closed
32
Calls
$1.32M
Puts
$3.45M
Net Calls
-$2.13M
Net Calls Change
-$52K
Top Buyers
| 1 |
CC
1
Commodore Capital
New York
|
$13.5M |
| 2 |
2
Millennium Management
New York
|
$9.32M |
| 3 |
3
BlackRock
New York
|
$27.1M |
| 4 |
4
Renaissance Technologies
New York
|
$4.04M |
| 5 |
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$2.36M |
